NS4B decreases TRIF protein level. by Yisha Liang (5244368)

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…The corresponding cross section height measurements show a height decrease by slightly less than 100 nm (from ∼10 nm to −100 nm in the encircled area; lower panel); the arrow in the AFM images points to an intact intercellular connection before cutting (<b>E1</b>) and the disappearance thereof after cutting (<b>E2</b>). …”

HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

“…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …”

HCV infection decreases MIN6 cell viability. by Qian Wang (32718)

TGFβ1 expression was increased, and RASAL1 expression was decreased in NTM cells in response to a hypoxic environment. by Fiona McDonnell (2636635)

“…A 0hr Control was set to 100%, and the normoxic and hypoxic results were presented as a percentage of this; Normoxic = 95.5%, Hypoxic = 159.4% (P<0.01). n = 3 *P<0.05, **P<0.01. …”

GO treatment decreased SR-B1 levels. by Claudia Sticozzi (329024)

Plasma IL-6 in PASC is higher than RC and correlates with frequency of SARS-CoV-2-specific TNF-α producing CD8⁺ T cells. by Katherine M. Littlefield (12647420)

The m⁶A peak of 3’UTR of TLR4 mRNA decreases significantly in METTL14-knockdown PK-15 cells. by Jing Chen (4762)

VEGF mutants demonstrated increased VE-cadherin expression compared to littermates, while sFlt-1 mutants demonstrated decreased expression. by Christopher R. Schlieve (3179439)

Binding mode of clavulanic acid with active site residues of SHV S130G mutant at different time intervals (a) binding of ca at 0 ns (b) binding of ca at 2 ns (c) binding of ca at 5... by Mohd Hassan Baig (441304)

The combination of LPS and PFC caused faster clot initiation and decreased clot strength. by Heather F. Pidcoke (9023789)

“…Comparing groups, there is a significant decline in TEG MA in LPS-PFC3 group compared to LPS-SAL group at T72 and T96 time points (p<0.05). …”

The Karolinska Sleepiness Scale (KSS) is a 9-point Likert scale, ranging from “extremely 1 = alert” to “9 = extremely sleepy–fighting sleep” [44]. by Marcel F. Hinss (14675457)

Diverse stress conditions trigger a rapid and dramatic decrease in miR-520b-3p and a corresponding increase in ATF5 mRNA over time in HeLa cells. by Kari A. Gaither (9046190)

Placental gene expression at E9.5 and E11.5. by Hui Zhao (7395)

Heatmap of metabolites with at least 1.5-fold change (increase or decrease) from 0h following treatment with or without PMA for 5 and 15 min. by Susama Chokesuwattanaskul (5813888)

Average predicted probabilities for top 5 publications & average initial placement rankings, controlling for ability, as a function of Alma mater ranking. by Sergey V. Popov (6719075)

Synthesis of 1<i>H</i>‑Pyrazol-5-yl-pyridin-2-yl-[1,2,4]triazinyl Soft-Lewis Basic Complexants via Metal and Oxidant Free [3 + 2] Dipolar Cycloaddition of Terminal Ethynyl Pyridine... by Giri Babu Veerakanellore (7388243)

Subjects:

Synthesis of 1<i>H</i>‑Pyrazol-5-yl-pyridin-2-yl-[1,2,4]triazinyl Soft-Lewis Basic Complexants via Metal and Oxidant Free [3 + 2] Dipolar Cycloaddition of Terminal Ethynyl Pyridine... by Giri Babu Veerakanellore (7388243)

Subjects:

Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

“…(<b>B</b>) ChIP analysis of <i>PC3</i> binding to the <i>Id3</i> promoter in PC12 cells, treated as shown in (<b>A</b>). A scheme above the graph describes the <i>Id3</i> gene and the promoter region analyzed, 700 nt 5′ to the transcription start. …”

Predicted metabolite levels for each reaction intermediate shown in Figure 7 under conditions in which the NAD+:NADH ratio is 31 (Bennett et al. [26]), or decreased by either 0.1-f... by William R. Cannon (608586)